Page last updated: 2024-09-04

resiquimod and Cytomegalovirus

resiquimod has been researched along with Cytomegalovirus in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aukrust, P; Beiske, KH; Fevang, B; Fløisand, Y; Frøland, S; Olweus, J; Rollag, H; Taraldsrud, E	1
Betts, MR; Brenchley, JM; Khojasteh, S; Koup, RA; Kuruppu, J; Loré, K; Perfetto, S; Roederer, M; Seder, RA	1

Other Studies

2 other study(ies) available for resiquimod and Cytomegalovirus

Article	Year
Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9. Clinical and experimental immunology, 2014, Volume: 175, Issue:3 Topics: Adult; Blood Cell Count; Bone Marrow Cells; Case-Control Studies; Common Variable Immunodeficiency; Cytomegalovirus; Dendritic Cells; Female; HLA-DR Antigens; Humans; Imidazoles; Inducible T-Cell Co-Stimulator Ligand; Intestine, Small; L-Selectin; Ligands; Male; Middle Aged; Receptors, CCR7; Spleen; Stem Cells; Toll-Like Receptor 7; Toll-Like Receptor 9	2014
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. Journal of immunology (Baltimore, Md. : 1950), 2003, Oct-15, Volume: 171, Issue:8 Topics: Adjuvants, Immunologic; Antigen-Presenting Cells; CD4-Positive T-Lymphocytes; Cell Differentiation; Cells, Cultured; CpG Islands; Cytomegalovirus; Dendritic Cells; Epitopes, T-Lymphocyte; HIV-1; Humans; Imidazoles; Interferon-alpha; Interleukin-12; Ligands; Lipopolysaccharides; Membrane Glycoproteins; Myeloid Cells; Oligodeoxyribonucleotides; Poly I-C; Protein Subunits; Receptors, Cell Surface; T-Lymphocyte Subsets; Toll-Like Receptor 3; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 9; Toll-Like Receptors	2003

Article

Year

Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.

Clinical and experimental immunology, 2014, Volume: 175, Issue:3

Topics: Adult; Blood Cell Count; Bone Marrow Cells; Case-Control Studies; Common Variable Immunodeficiency; Cytomegalovirus; Dendritic Cells; Female; HLA-DR Antigens; Humans; Imidazoles; Inducible T-Cell Co-Stimulator Ligand; Intestine, Small; L-Selectin; Ligands; Male; Middle Aged; Receptors, CCR7; Spleen; Stem Cells; Toll-Like Receptor 7; Toll-Like Receptor 9

2014

Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.

Journal of immunology (Baltimore, Md. : 1950), 2003, Oct-15, Volume: 171, Issue:8

Topics: Adjuvants, Immunologic; Antigen-Presenting Cells; CD4-Positive T-Lymphocytes; Cell Differentiation; Cells, Cultured; CpG Islands; Cytomegalovirus; Dendritic Cells; Epitopes, T-Lymphocyte; HIV-1; Humans; Imidazoles; Interferon-alpha; Interleukin-12; Ligands; Lipopolysaccharides; Membrane Glycoproteins; Myeloid Cells; Oligodeoxyribonucleotides; Poly I-C; Protein Subunits; Receptors, Cell Surface; T-Lymphocyte Subsets; Toll-Like Receptor 3; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 9; Toll-Like Receptors

2003